Maiwald

Kerstin Wolff of Maiwald explains how the EU’s provisional agreement on plants generated by new genomic techniques divides them into two categories, opening the market while preserving patent and regulatory oversight

Senior intellectual property practitioners from Maiwald discuss how innovators can secure robust patent protection for AI inventions amid evolving EPO practice and accelerating technological change

Marco Stief of Maiwald argues that the District Court of The Hague missed an opportunity to clarify the uncertainty surrounding the term ‘first authorisation’ in Article 3(d) of the SPC Regulation in a recent judgment

Fabian Kiendl and Christian Schäflein of Maiwald examine how AI engineering can yield patentable inventions and consider the protection of such solutions in automotive technology under the European Patent Convention

Kerstin Wolff and Tobias Matschke of Maiwald Intellectual Property examine a landmark Unified Patent Court decision on second medical use claims and compare it with Germany’s established approach to ‘skinny label’ products

Kerstin Wolff of Maiwald Intellectual Property examines the EU’s winding path towards the regulation of new genomic techniques, with a proposed patent ban remaining a key source of contention